Beauty Health (NASDAQ:SKIN – Get Rating) had its price objective raised by DA Davidson from $25.00 to $30.00 in a research report released on Friday, The Fly reports. The brokerage currently has a buy rating on the stock.
A number of other analysts have also recently issued reports on the company. Canaccord Genuity Group dropped their price objective on Beauty Health from $22.00 to $20.00 in a report on Thursday, June 30th. Piper Sandler dropped their price objective on Beauty Health from $22.00 to $20.00 and set an overweight rating on the stock in a report on Wednesday, August 10th. Canaccord Genuity Group decreased their target price on Beauty Health from $22.00 to $20.00 and set a buy rating on the stock in a research note on Thursday, June 30th. Finally, The Goldman Sachs Group decreased their target price on Beauty Health from $25.00 to $22.00 and set a buy rating on the stock in a research note on Tuesday, August 16th. One research analyst has rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of Moderate Buy and an average target price of $25.00.
Beauty Health Stock Performance
Shares of SKIN opened at $11.98 on Friday. The stock’s 50-day simple moving average is $12.76 and its 200 day simple moving average is $13.88. The stock has a market capitalization of $1.81 billion, a price-to-earnings ratio of -6.21 and a beta of 1.49. The company has a debt-to-equity ratio of 2.08, a quick ratio of 10.59 and a current ratio of 11.44. Beauty Health has a 52-week low of $9.94 and a 52-week high of $30.17.
Hedge Funds Weigh In On Beauty Health
Beauty Health Company Profile
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.
- Get a free copy of the StockNews.com research report on Beauty Health (SKIN)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- MarketBeat: Week in Review 9/12 – 9/16
- Is There a Cure for What is Ailing Teladoc Stock?
- No One Told These 3 Stocks It’s a Down Week
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.